ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SAR Sareum Holdings Plc

24.00
-0.50 (-2.04%)
03 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00BMC3RJ87 ORD GBP 0.0125
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -2.04% 24.00 23.00 25.00 24.50 23.00 24.50 275,939 13:19:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -3.42M -0.0317 -7.57 26.45M
Sareum Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 24.50p. Over the last year, Sareum shares have traded in a share price range of 10.20p to 67.50p.

Sareum currently has 107,950,000 shares in issue. The market capitalisation of Sareum is £26.45 million. Sareum has a price to earnings ratio (PE ratio) of -7.57.

Sareum Share Discussion Threads

Showing 19001 to 19021 of 19175 messages
Chat Pages: 767  766  765  764  763  762  761  760  759  758  757  756  Older
DateSubjectAuthorDiscuss
29/10/2024
22:25
Oh no...

You have been reported as a critical thinker...

And then the world will no longer be able to share your wonderful "insights"

When's that takeover happening...

Get your meds taken and get to bed...

More share price falls for you to try and excuse tomorrow...

wolfofwallstreets
29/10/2024
21:46
So you report an individual logged as critical thinker but report as critical stinker...I notice the aliases on lse are in motion.
ADVFN effectively with their investments criteria need to clean up here.
And lse will see you being silenced will be noteable

criticalthinker1
29/10/2024
21:31
Just reported you as well criticalstinker..
wolfofwallstreets
29/10/2024
21:26
Criticalstinker...

I can imagine advfn will actively work through the night...

I hear emma walmsley is also involved..

Utter loon of a man..

wolfofwallstreets
29/10/2024
21:25
Yeah...I don't think that's gonna happen...

How's your family?

Sorry..forgot...they have nothing more to do with you eh hahaha

wolfofwallstreets
29/10/2024
21:17
And you have other logins....well hopefully the ADVFN team can deal with that too!
criticalthinker1
29/10/2024
21:16
My only social life?

I can guarantee you it is not. But that would not deter you from your obvious determination to avoid positive speculation here.

I have reported you. Hopefully the ADVFN team see these posts in the morning.

criticalthinker1
29/10/2024
20:19
No criticalstinker..that's what's you're saying...

You don't like anyone who isn't a ramper...

Stick to your anti vax garbage and chatting about thoth2..this page is your only social life...

Report away...

Will just use another one of my logins...

wolfofwallstreets
29/10/2024
19:54
So wolf are you saying the individuals and corporate..s ...are putting money into Sareum because they see a means to work the market capital and worth of Sareum?
That's libellous chap.
You need to report the funding to the relevant body. As the board will have to respond you such an insinuation.
Or maybe you get reported for disemmenation of discussion that proports a positive indication.
I've not reported anyone yet but this will be my first.

criticalthinker1
29/10/2024
18:38
I didn't get to view the ivm. But reading some of the posts on lse it seems the ducks are lining up.
The toxicology studies will offer a greater platform as a prerequisite to ph2. Some companies have parameters within their own corporate governance and shareholders responsibility as to when they can show their hand! Fact

This also will also further validate numerous patents approved and pending.
As per the corporate objectives of Sareum this is commensurate with such objectives.
Until I get to hear the upload about the inferred potential of more than one pharma actually requesting such requirements then imo its only a matter of time until a bidding scenario commences.
It's akin to a poker game.
Who shows their hand/interest first...Once that happens then whoosh...
All best Steadydanny 👌

criticalthinker1
29/10/2024
17:27
The happy clappy rampers will never let reality dampen their spirits lol...
wolfofwallstreets
29/10/2024
17:00
Another great day for sareum...

More falls...

wolfofwallstreets
29/10/2024
15:56
well mong, the BOD are just a load of ramping idiots
horridhenry
29/10/2024
15:47
And lse take the little breadcrumbs and the cycle starts over..

Partner companies...opportunities...

Then nothing for months...

Then 737 will get handed back...

Share price will collapse..

Then they will release some news...

Share price recovers...

More placings...

Then the next annual meeting..

wolfofwallstreets
29/10/2024
15:40
i'm buying some in a minute, look out for a big buy!
horridhenry
29/10/2024
15:38
had to laugh partner companies haha maybe all the pharmas are going to chip together to license 1801
iamhappy1
29/10/2024
15:29
pretty clear that all 3 of our leaders are holding a lot back.
There can only be an nda in place

The response about a new CEO appointment was telling - no point in several scenarios

reassuring i would say

horridhenry
29/10/2024
15:12
Jam tomorrow...the science...
wolfofwallstreets
29/10/2024
13:23
1*
Sareum Holdings plc, a biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, posted weak FY numbers for the year ended 30 June 2024 this morning. The Group reported another loss on ordinary activities after taxation for the year ended 30 June 2024 of £3.4 million a little larger than the £3.2 million loss for the year ended 30 June 2023. The business has not managed to generate revenue yet let alone profit and continues to raise funds to exist. Post period end, the Company completed fundraises totalling £3.4 million (before expenses), from certain high net worth individuals, corporates and institutions, via subscriptions for a total of 16,264,444 new ordinary shares...

...from WealthOracle

wealthoracle.co.uk/detailed-result-full/SAR/924

martinmc123
29/10/2024
10:51
Jam tomorrow lol...
wolfofwallstreets
29/10/2024
08:09
Lse really needs workinginpharma back to tell them...wink wink nudge nudge..what is happening with 737...

At least his dreck gave them hope...

Lol..

wolfofwallstreets
Chat Pages: 767  766  765  764  763  762  761  760  759  758  757  756  Older

Your Recent History

Delayed Upgrade Clock